US 10577382
Fused heterocyclic compound
granted A61KA61K31/444A61K31/4985
Quick answer
US patent 10577382 (Fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/444, A61K31/4985, A61K31/5025, A61K31/519